Basic Information
KayoThera, Inc. is an early-stage therapeutic company focused on developing novel cancer immunotherapy drugs. KayoThera is developing treatments for advanced and metastatic cancers, including breast cancer, lung cancer, pancreatic cancer, colorectal cancer, brain cancer, and kidney cancer. The company was initially funded by Foundation Venture Capital Group (FVCG).
KayoThera, Inc.
Princeton,NewJersey,United States of America
less than 15 people
January 01, 2019
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios